The scale of the problem was highlighted in March when authorities set ablaze $645 million worth of counterfeit medicines ...

A long-running struggle in Nigeria against fake medicines has become even harder because widespread economic hardship is ...

Porous borders and weak regulations ... leaving a void in the market. US giant Pfizer recently shuttered its operations in the country, while British multinational GlaxoSmithKline and French ...

Something seems to be going awry with GlaxoSmithKline's game plan for ... respectively 32 and 35 per cent shy of analyst predictions. Weakness in the respiratory franchise - along with what ...

When Prince Amuniwaiye ascended the throne of his fathers, it looked like he would do well. Oyo had looked forward to a new ...

Top forecasters on Wall Street are eying the risk of a recession, a global slowdown, and further stock drops ahead.

Deutsche Bank analyst Emmanuel Papadakis maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...

US stocks represent nearly 50% of total world market cap and 65% of the MSCI World ... 35 (depending on how you measure it). The last weak dollar period, from 2003 to 2008, saw the US P/E decline ...

The current sell-off in the US stock market is now the 15 th steepest decline from the previous peak, based on the S&P 500 ...